Condition: Breast Cancer · Sponsor: The Netherlands Cancer Institute
This study is a prospective, multicenter study in which a serum sample will be collected at the day of starting neo adjuvant treatment in breast cancer patients
This description comes directly from the study's public registry record.
Sabine Linn, MD · +31205129111 · s.linn@nki.nl
Ingrid Mandjes · i.mandjes@nki.nl
Always discuss trial participation with your own doctor first.
| Antoni van Leeuwenhoek | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06273800